SMWB Stock Analysis: SimilarWeb | NYSE
Software - Application | NYSE, USA | Market Cap: 635m USD | 12M Return: 23.8% | IL0011751653 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.61M
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Similarweb Ltd. (NYSE: SMWB) is a digital data and analytics provider headquartered in Givatayim, Israel, operating in the application software segment of the information technology sector. The company operates a subscription-based SaaS business model, delivering competitive intelligence and market research data to business customers across the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and other international markets.
The company offers a portfolio of analytics solutions covering web intelligence, app intelligence, sales intelligence, retail intelligence, and stock intelligence. These tools enable customers to benchmark performance against competitors, analyze market trends, monitor digital acquisition strategies, track mobile app usage, generate leads from digital buying signals, study consumer purchase journeys, and conduct investment research and due diligence. The company also provides data-as-a-service, bespoke datasets, and advisory services.
Similarweb serves a diverse customer base across multiple industries, including retail, consumer packaged goods, consumer finance, consultancies, marketing and advertising agencies, media and publishers, business-to-business software, payment processors, travel, institutional investors, and luxury and premium consumer brands. The company was incorporated in 2009 and completed its initial public offering on May 12, 2021.
- Subscription revenue growth driven by enterprise customer expansion
- Path to profitability hinges on operating margin improvement
- Competition from free analytics tools pressures pricing and market share
| Net Income: -30.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -5.99 > 1.0 |
| NWC/Revenue: -22.50% < 20% (prev -18.57%; Δ -3.94% < -1%) |
| CFO/TA 0.04 > 3% & CFO 10.0m > Net Income -30.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.3m) vs 12m ago 4.98% < -2% |
| Gross Margin: 79.43% > 18% (prev 78.27%; Δ 1.16% > 0.5%) |
| Asset Turnover: 117.0% > 50% (prev 108.6%; Δ 8.43% > 0%) |
| Interest Coverage Ratio: -1.76 > 6 (EBIT TTM -15.5m / Interest Expense TTM 8.78m) |
| A: -0.25 (Total Current Assets 128.1m - Total Current Liabilities 193.2m) / Total Assets 257.1m |
| B: -1.57 (Retained Earnings -403.9m / Total Assets 257.1m) |
| C: -0.06 (EBIT TTM -15.5m / Avg Total Assets 247.4m) |
| D: 0.09 (Book Value of Equity 20.8m / Total Liabilities 236.2m) |
| Altman-Z'' = -7.11 = D |
| DSRI: 1.08 (Receivables 48.6m/40.0m, Revenue 289.4m/258.0m) |
| GMI: 0.99 (GM 78.27% / 79.43%) |
| AQI: 1.38 (AQ_t 0.29 / AQ_t-1 0.21) |
| SGI: 1.12 (Revenue 289.4m / 258.0m) |
| TATA: -0.16 (NI -30.0m - CFO 10.0m) / TA 257.1m) |
| Beneish M = -2.68 (Cap -4..+1) = A |
As of August 13, 2026, the stock is trading at USD 8.79 with a total of 5,450,983 shares traded. Over the past week, the price has changed by +18.15%, over one month by +23.28%, over three months by +181.73% and over the past year by +23.80%.
Current recommended Stop Loss: 8.30 (which is 5.6% or 1.3 ATR below the current price).
SimilarWeb has received a consensus analysts rating of 4.56. Therefore, it is recommended to buy SMWB.
- StrongBuy: 5
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 6.1 | -30.6% |
P/E Forward = 49.505
P/S = 2.1946
P/B = 31.2123
Revenue TTM = 289.4m USD
EBIT TTM = -15.5m USD
EBITDA TTM = -6.50m USD
Long Term Debt = 33.0m USD (estimated: total debt 39.4m - short term 6.41m)
Short Term Debt = 6.41m USD (from shortTermDebt, last quarter)
Debt = 39.4m USD (from shortLongTermDebtTotal, last quarter) (leases 39.4m already included)
Net Debt = -32.3m USD (calculated: Debt 39.4m - CCE 71.7m)
Enterprise Value = 602.8m USD (635.1m + Debt 39.4m - CCE 71.7m)
Interest Coverage Ratio = -1.76 (Ebit TTM -15.5m / Interest Expense TTM 8.78m)
EV/FCF = 70.63x (Enterprise Value 602.8m / FCF TTM 8.54m)
FCF Yield = 1.42% (FCF TTM 8.54m / Enterprise Value 602.8m)
FCF Margin = 2.95% (FCF TTM 8.54m / Revenue TTM 289.4m)
Net Margin = -10.38% (Net Income TTM -30.0m / Revenue TTM 289.4m)
Gross Margin = 79.43% ((Revenue TTM 289.4m - Cost of Revenue TTM 59.5m) / Revenue TTM)
Gross Margin QoQ = 78.83% (prev 79.35%)
Tobins Q-Ratio = 2.34 (Enterprise Value 602.8m / Total Assets 257.1m)
Interest Expense / Debt = 22.30% (Interest Expense 8.78m / Debt 39.4m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -12.2m (EBIT -15.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.66 (Total Current Assets 128.1m / Total Current Liabilities 193.2m)
Debt / Equity = 1.89 (Debt 39.4m / totalStockholderEquity, last quarter 20.8m)
Debt / EBITDA = 4.97 (negative EBITDA) (Net Debt -32.3m / EBITDA -6.50m)
Debt / FCF = -3.78 (Net Debt -32.3m / FCF TTM 8.54m)
Total Stockholder Equity = 23.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -12.14% (Net Income -30.0m / Total Assets 257.1m)
RoE = -129.6% (Net Income TTM -30.0m / Total Stockholder Equity 23.2m)
RoCE = -27.54% (EBIT -15.5m / Capital Employed (Equity 23.2m + L.T.Debt 33.0m))
RoIC = -21.89% (negative operating profit) (NOPAT -12.2m / Invested Capital 55.8m)
WACC = 11.80% (E(635.1m)/V(674.5m) * Re(11.44%) + D(39.4m)/V(674.5m) * Rd(22.30%) * (1-Tc(0.21)))
Discount Rate = 11.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.78 | Cagr: 4.86%
[DCF] Terminal Value 61.39% ; FCFF base≈14.0m ; Y1≈12.3m ; Y5≈9.90m
[DCF] Fair Price = 1.53 (EV 101.7m - Net Debt -32.3m = Equity 134.0m / Shares 87.6m; r=11.80% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.45 | # QB: 0
Revenue Correlation: 99.80 | Revenue CAGR: 13.58% | SUE: 0.47 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.03 | Chg30d=N/A | Revisions=-73% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.04 | Chg30d=+0.00% | Revisions=-50% | Analysts=8
EPS current Year (2026-12-31): EPS=0.14 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=+140.6% | GrowthRev=+9.9%
EPS next Year (2027-12-31): EPS=0.23 | Chg30d=-2.09% | Revisions=-50% | GrowthEPS=+62.6% | GrowthRev=+9.3%
[Analyst] Revisions Ratio: -71% (up=2, down=19)